Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven research firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) shares rose 2.7% on Monday . The company traded as high as $29.57 and last traded at $29.22. Approximately 295,122 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 990,351 shares. The stock had previously closed at $28.46. Analyst Upgrades […]
01.02.2024 - REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) - Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the .
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) General Counsel Jeff Cislini sold 1,500 shares of Revolution Medicines stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $27.00, for a total value of $40,500.00. Following the sale, the general counsel now owns 36,126 shares in the company, […]
Brokerages Set Revolution Medicines, Inc (NASDAQ:RVMD) Price Target at $36 82 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.